tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CGEN Stock Latest News

Compugen Reports Q3 2025 Results and Clinical Progress
Company AnnouncementsCompugen Reports Q3 2025 Results and Clinical Progress
6d ago
CGEN
Compugen’s Earnings Call: Strategic Focus Amid Financial Challenges
PremiumCompany Announcements
Compugen’s Earnings Call: Strategic Focus Amid Financial Challenges
6d ago
CGEN
Compugen Reports Q3 2025 Results and Advances Clinical Trials
PremiumCompany Announcements
Compugen Reports Q3 2025 Results and Advances Clinical Trials
6d ago
6K
CGEN
Compugen reports Q3 EPS (7c), consensus (9c)
PremiumThe Fly
Compugen reports Q3 EPS (7c), consensus (9c)
6d ago
CGEN
CGEN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
CGEN Earnings this Week: How Will it Perform?
8d ago
CGEN
Compugen’s COM701 Trial: A Potential Game-Changer in Ovarian Cancer Treatment
PremiumCompany AnnouncementsCompugen’s COM701 Trial: A Potential Game-Changer in Ovarian Cancer Treatment
20d ago
CGEN
Compugen Presents Promising COM701 Analysis at ESMO 2025
Premium
Company Announcements
Compugen Presents Promising COM701 Analysis at ESMO 2025
1M ago
6K
CGEN
Compugen’s Shareholders Approve All Proposals at 2025 Annual Meeting
Premium
Company Announcements
Compugen’s Shareholders Approve All Proposals at 2025 Annual Meeting
2M ago
6K
CGEN
Compugen’s Earnings Call: Strategic Gains Amid Financial Hurdles
PremiumCompany Announcements
Compugen’s Earnings Call: Strategic Gains Amid Financial Hurdles
3M ago
CGEN
Compugen’s COM701 Trial: A Potential Game-Changer in Ovarian Cancer Treatment?
PremiumCompany Announcements
Compugen’s COM701 Trial: A Potential Game-Changer in Ovarian Cancer Treatment?
3M ago
CGEN
Compugen price target raised to $13 from $10 at Leerink
PremiumThe Fly
Compugen price target raised to $13 from $10 at Leerink
3M ago
AZN
CGEN
Compugen Reports Q2 2025 Results and Strategic Progress
PremiumCompany Announcements
Compugen Reports Q2 2025 Results and Strategic Progress
3M ago
CGEN
Compugen Ltd. Announces 2025 Annual General Meeting Details
PremiumCompany AnnouncementsCompugen Ltd. Announces 2025 Annual General Meeting Details
3M ago
6K
CGEN
Compugen Reports Q2 2025 Results and Advances in Immuno-Oncology Trials
Premium
Company Announcements
Compugen Reports Q2 2025 Results and Advances in Immuno-Oncology Trials
3M ago
6K
CGEN
Compugen reports Q2 EPS (8c), consensus (9c)
Premium
The Fly
Compugen reports Q2 EPS (8c), consensus (9c)
3M ago
CGEN
CGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CGEN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
CGEN
Compugen’s COM701 Trial: A New Hope for Ovarian Cancer?
PremiumCompany Announcements
Compugen’s COM701 Trial: A New Hope for Ovarian Cancer?
4M ago
CGEN
Compugen Initiates Global Trial for COM701 in Ovarian Cancer
PremiumCompany Announcements
Compugen Initiates Global Trial for COM701 in Ovarian Cancer
4M ago
6K
CGEN
Compugen begins dosing in ovarian cancer trial
PremiumThe Fly
Compugen begins dosing in ovarian cancer trial
4M ago
CGEN
Compugen’s COM701 Trial: A Potential Game-Changer in Ovarian Cancer Treatment?
PremiumCompany AnnouncementsCompugen’s COM701 Trial: A Potential Game-Changer in Ovarian Cancer Treatment?
4M ago
CGEN
Compugen’s Long-Term Value Potential: Buy Rating Backed by AstraZeneca Partnerships and Financial Stability
Premium
Ratings
Compugen’s Long-Term Value Potential: Buy Rating Backed by AstraZeneca Partnerships and Financial Stability
6M ago
CGEN
Compugen’s Q1 2025: Clinical Progress and Financial Stability
Premium
Company Announcements
Compugen’s Q1 2025: Clinical Progress and Financial Stability
6M ago
CGEN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >